Syndax Pharmaceuticals Inc Annual Return On Assets in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from 2016 to 2024.
  • Syndax Pharmaceuticals Inc Return On Assets for the quarter ending December 31, 2024 was -58.7 %, a 33.5% decline year-over-year.
  • Syndax Pharmaceuticals Inc annual Return On Assets for 2024 was -58.7 %, a 33.5% decline from 2023.
  • Syndax Pharmaceuticals Inc annual Return On Assets for 2023 was -44 %, a 24.2% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Return On Assets for 2022 was -35.4 %, a 538% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -58.7 -14.7 -33.5% Jan 1, 2024 Dec 31, 2024
2023 -44 -8.56 -24.2% Jan 1, 2023 Dec 31, 2023
2022 -35.4 -43.5 -538% Jan 1, 2022 Dec 31, 2022
2021 8.09 +45.7 Jan 1, 2021 Dec 31, 2021
2020 -37.6 +31 +45.2% Jan 1, 2020 Dec 31, 2020
2019 -68.6 +4.29 +5.88% Jan 1, 2019 Dec 31, 2019
2018 -72.9 -23.7 -48.1% Jan 1, 2018 Dec 31, 2018
2017 -49.2 -13 -35.8% Jan 1, 2017 Dec 31, 2017
2016 -36.2 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.